The composite solubility versus pH profile and its role in intestinal absorption prediction
暂无分享,去创建一个
Michael B. Bolger | M. Félix | M. Bolger | Barry A. Hendriksen | Manuel V. Sanchez Felix | B. Hendriksen
[1] William H. Press,et al. Numerical recipes , 1990 .
[2] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[3] J. Devane. Oral drug delivery technology : Addressing the solubility/permeability paradigm , 1998 .
[4] W H Streng,et al. General treatment of pH-solubility profiles of weak acids and bases and the effects of different acids on the solubility of a weak base. , 1984, Journal of pharmaceutical sciences.
[5] A. Beresford,et al. The emerging importance of predictive ADME simulation in drug discovery. , 2002, Drug discovery today.
[6] Tommy Liljefors,et al. Correlation of aqueous solubility of salts of benzylamine with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 2002, International journal of pharmaceutics.
[7] B. Müller,et al. Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption , 1999, Pharmaceutical Research.
[8] Ulf Norinder,et al. Experimental and Computational Screening Models for Prediction of Aqueous Drug Solubility , 2002, Pharmaceutical Research.
[9] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[10] G. Flynn,et al. Solubility of organic hydrochlorides. , 1972, Journal of pharmaceutical sciences.
[11] W. L. Jorgensen,et al. Prediction of drug solubility from structure. , 2002, Advanced drug delivery reviews.
[12] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[13] H Lennernäs,et al. Membrane transport of drugs in different regions of the intestinal tract of the rat. , 1998, Journal of pharmaceutical sciences.
[14] Veerabahu Shanmugasundaram,et al. Estimation of Aqueous Solubility of Organic Compounds with QSPR Approach , 2002, Pharmaceutical Research.
[15] J. Topliss,et al. QSAR model for drug human oral bioavailability. , 2000, Journal of medicinal chemistry.
[16] Thomas J. Raub,et al. Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. , 1995, Journal of pharmaceutical sciences.
[17] B. Schug,et al. The biopharmaceutics classification system (BCS): class III drugs - better candidates for BA/BE waiver? , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[18] John G. Topliss,et al. QSAR Model for Drug Human Oral Bioavailability1 , 2000 .